Show simple item record

dc.contributor.authorSchwartzberg, L.
dc.contributor.authorBroder, M.S.
dc.contributor.authorAilawadhi, S.
dc.contributor.authorBeltran, H.
dc.contributor.authorBlakely, L.J.
dc.contributor.authorBudd, G.T.
dc.contributor.authorCarr, L.
dc.contributor.authorCecchini, M.
dc.contributor.authorCobb, P.
dc.contributor.authorKansal, A.
dc.contributor.authorKim, A.
dc.contributor.authorMonk, B.J.
dc.contributor.authorWong, D.J.
dc.contributor.authorCampos, C.
dc.contributor.authorYermilov, I.
dc.date.accessioned2023-12-22T05:06:56Z
dc.date.available2023-12-22T05:06:56Z
dc.date.issued2022-12-21
dc.identifier.citationSchwartzberg, L., Broder, M. S., Ailawadhi, S., Beltran, H., Blakely, L. J., Budd, G. T., Carr, L., Cecchini, M., Cobb, P., Kansal, A., Kim, A., Monk, B. J., Wong, D. J., Campos, C., & Yermilov, I. (2022). Impact of early detection on cancer curability: A modified Delphi panel study. PLoS ONE, 17(12 December).
dc.identifier.issn1932-6203
dc.identifier.pmid36542647
dc.identifier.doi10.1371/journal.pone.0279227
dc.identifier.urihttp://hdl.handle.net/10150/670591
dc.description.abstractExpert consensus on the potential benefits of early cancer detection does not exist for most cancer types. We convened 10 practicing oncologists using a RAND/UCLA modified Delphi panel to evaluate which of 20 solid tumors, representing >40 American Joint Committee on Cancer (AJCC)-identified cancer types and 80% of total cancer incidence, would receive potential clinical benefits from early detection. Pre-meeting, experts estimated how long cancers take to progress and rated the current curability and benefit (improvement in curability) of an annual hypothetical multi-cancer screening blood test. Post-meeting, experts rerated all questions. Cancers had varying estimates of the potential benefit of early cancer detection depending on estimates of their curability and progression by stage. Cancers rated as progressing quickly and being curable in earlier stages (stomach, esophagus, lung, urothelial tract, melanoma, ovary, sarcoma, bladder, cervix, breast, colon/rectum, kidney, uterus, anus, head and neck) were estimated to be most likely to benefit from a hypothetical screening blood test. Cancer types rated as progressing quickly but having comparatively lower cure rates in earlier stages (liver/intrahepatic bile duct, gallbladder, pancreas) were estimated to have medium likelihood of benefit from a hypothetical screening blood test. Cancer types rated as progressing more slowly and having higher curability regardless of stage (prostate, thyroid) were estimated to have limited likelihood of benefit from a hypothetical screening blood test. The panel concluded most solid tumors have a likelihood of benefit from early detection. Even among difficult-to-treat cancers (e.g., pancreas, liver/ intrahepatic bile duct, gallbladder), early-stage detection was believed to be beneficial. Based on the panel consensus, broad coverage of cancers by screening blood tests would deliver the greatest potential benefits to patients. © 2022 Schwartzberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.language.isoen
dc.publisherPublic Library of Science
dc.rights© 2022 Schwartzberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleImpact of early detection on cancer curability: A modified Delphi panel study
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, HonorHealth Research Institute, University of Arizona
dc.identifier.journalPLoS ONE
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitlePLoS ONE
refterms.dateFOA2023-12-22T05:06:56Z


Files in this item

Thumbnail
Name:
journal.pone.0279227.pdf
Size:
747.5Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© 2022 Schwartzberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
Except where otherwise noted, this item's license is described as © 2022 Schwartzberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.